{"database": "openregs", "table": "documents", "rows": [["FDA-1977-N-0013-0032", "FDA", "FDA-1977-N-0013", "Reference 56 - Eastern Research Group, Inc. \"Cost Benefit Analysis of Proposed FDA Rule on Overthe-Counter Internal Analgesic, Antipyretic, and Antirheumatic Drug Products; Required Warnings,\" Final Report, October 6, 2004, with Addendum, July 30, 2007. re: Background Material from FDA (Part 2 of Reference 56)", "Supporting & Related Material", "Background Material", "2009-04-29T04:00:00Z", 2009, 4, null, null, "2019-02-06T14:05:23Z", null, 0, 0, "0900006480829234"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1977-N-0013-0032"], "units": {}, "query_ms": 0.3926211502403021, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}